Paul Chaplin

4.8k total citations
71 papers, 3.2k citations indexed

About

Paul Chaplin is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Paul Chaplin has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 33 papers in Molecular Biology and 31 papers in Virology. Recurrent topics in Paul Chaplin's work include Poxvirus research and outbreaks (30 papers), Immunotherapy and Immune Responses (29 papers) and Virus-based gene therapy research (16 papers). Paul Chaplin is often cited by papers focused on Poxvirus research and outbreaks (30 papers), Immunotherapy and Immune Responses (29 papers) and Virus-based gene therapy research (16 papers). Paul Chaplin collaborates with scholars based in Switzerland, United States and Australia. Paul Chaplin's co-authors include Mark Suter, Robert A. Collins, Jens Vollmar, Jean‐Pierre Y. Scheerlinck, Jürgen Hausmann, Darja Schmidt, Hubertus Hochrein, Alfred von Krempelhuber, Henning Lauterbach and Jan M. Tennent and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Paul Chaplin

70 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Chaplin Switzerland 35 1.4k 1.3k 1.3k 1.2k 658 71 3.2k
Deborah H. Fuller United States 31 1.2k 0.8× 1.4k 1.1× 2.3k 1.8× 1.4k 1.1× 1.2k 1.8× 77 4.2k
Lars Hangartner United States 25 1.9k 1.3× 908 0.7× 1.9k 1.5× 963 0.8× 861 1.3× 39 3.6k
John W. Wills United States 38 1.5k 1.0× 1.2k 0.9× 870 0.7× 1.9k 1.6× 686 1.0× 62 3.8k
Michael A. Chattergoon United States 30 986 0.7× 1.3k 1.0× 2.3k 1.8× 899 0.8× 719 1.1× 58 3.8k
Bimal K. Chakrabarti United States 28 2.4k 1.6× 948 0.7× 1.8k 1.4× 886 0.7× 1.1k 1.7× 55 3.6k
Lisa R. King United States 30 898 0.6× 921 0.7× 1.3k 1.0× 1.8k 1.5× 683 1.0× 59 3.1k
Ramesh Akkina United States 39 1.8k 1.2× 2.3k 1.8× 1.3k 1.0× 909 0.8× 1.1k 1.7× 102 4.7k
Michael S. Wyand United States 31 2.4k 1.7× 817 0.6× 2.1k 1.6× 1.3k 1.1× 969 1.5× 53 4.0k
Helen C. Perry United States 23 619 0.4× 1.4k 1.1× 1.9k 1.5× 1.7k 1.5× 830 1.3× 27 4.2k
Ke-Qin Xin Japan 31 526 0.4× 938 0.7× 1.2k 1.0× 977 0.8× 554 0.8× 59 2.8k

Countries citing papers authored by Paul Chaplin

Since Specialization
Citations

This map shows the geographic impact of Paul Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Chaplin more than expected).

Fields of papers citing papers by Paul Chaplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Chaplin. The network helps show where Paul Chaplin may publish in the future.

Co-authorship network of co-authors of Paul Chaplin

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Chaplin. A scholar is included among the top collaborators of Paul Chaplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Chaplin. Paul Chaplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Endt, Kathrin, Markus Kalla, Hubertus Hochrein, et al.. (2022). A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection. Frontiers in Immunology. 13. 841471–841471. 15 indexed citations
3.
Hinterberger, Maria, Barbara Bathke, Sonia Wennier, et al.. (2021). Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory. Journal for ImmunoTherapy of Cancer. 9(2). e001586–e001586. 16 indexed citations
4.
Lawrence, Steven J., Thomas Meyer, Darja Schmidt, et al.. (2020). Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine. The Journal of Infectious Diseases. 223(6). 1062–1072. 46 indexed citations
5.
Greenberg, Richard N., Christine M. Hay, Jack T. Stapleton, et al.. (2016). A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects. PLoS ONE. 11(6). e0157335–e0157335. 54 indexed citations
6.
Sonnenburg, Frank von, Ulf Darsow, Johannes Ring, et al.. (2014). Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis. Vaccine. 32(43). 5696–5702. 41 indexed citations
7.
Lauterbach, Henning, Barbara Bathke, Kay Brinkmann, et al.. (2013). Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity. Frontiers in Immunology. 4. 251–251. 12 indexed citations
8.
Frey, Sharon E., Patricia Winokur, Robert A. Salata, et al.. (2013). Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario. Vaccine. 31(29). 3025–3033. 50 indexed citations
9.
10.
Hausmann, Jürgen, Henning Lauterbach, Michaela Schmidt, et al.. (2008). Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. Journal of Clinical Investigation. 118(5). 1776–1784. 114 indexed citations
11.
Stittelaar, Koert J., Geert van Amerongen, Ivanela Kondova, et al.. (2005). Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus. Journal of Virology. 79(12). 7845–7851. 170 indexed citations
12.
Chaplin, Paul, et al.. (2005). Genetic stability of recombinant MVA-BN. Vaccine. 24(21). 4618–4621. 20 indexed citations
13.
Franchini, Marco, Sabine Vollstedt, Mathias Ackermann, et al.. (2004). Dendritic Cells from Mice Neonatally Vaccinated with Modified Vaccinia Virus Ankara Transfer Resistance against Herpes Simplex Virus Type I to Naive One-Week-Old Mice. The Journal of Immunology. 172(10). 6304–6312. 21 indexed citations
14.
Schirmbeck, Reinhold, Nicolás Fissolo, Paul Chaplin, & Jörg Reimann. (2003). Enhanced Priming of Multispecific, Murine CD8+ T Cell Responses by DNA Vaccines Expressing Stress Protein-Binding Polytope Peptides. The Journal of Immunology. 171(3). 1240–1246. 20 indexed citations
15.
Woodberry, Tonia, Joy Gardner, Suzanne Elliott, et al.. (2003). Prime Boost Vaccination Strategies: CD8 T Cell Numbers, Protection, and Th1 Bias. The Journal of Immunology. 170(5). 2599–2604. 49 indexed citations
16.
Scheerlinck, Jean‐Pierre Y., Gerard J. Casey, Peter McWaters, et al.. (2001). The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine. 19(28-29). 4053–4060. 59 indexed citations
17.
Chaplin, Paul, et al.. (2000). The Expression and Biologic Effects of Ovine Interleukin-4 on T and B Cell Proliferation. Journal of Interferon & Cytokine Research. 20(4). 419–425. 11 indexed citations
18.
Rose, Robert De, Jean‐Pierre Y. Scheerlinck, Gerard J. Casey, et al.. (2000). Ovine Interleukin-12: Analysis of Biologic Function and Species Comparison. Journal of Interferon & Cytokine Research. 20(6). 557–564. 21 indexed citations
19.
Chaplin, Paul, et al.. (1996). Cloning and Biologic Activities of a Bovine Interferon-α Isolated from the Epithelium of a Rotavirus-Infected Calf. Journal of Interferon & Cytokine Research. 16(1). 25–30. 18 indexed citations
20.
Chaplin, Paul, K.R. Parsons, & Robert A. Collins. (1996). The cloning of cattle interferon-A subtypes Isolated from the gut epithelium of rotavirus-infected calves. Immunogenetics. 44(2). 143–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah H. Fuller Breakdown of academic impact, for papers by Lars Hangartner Breakdown of academic impact, for papers by John W. Wills Breakdown of academic impact, for papers by Michael A. Chattergoon Breakdown of academic impact, for papers by Bimal K. Chakrabarti Breakdown of academic impact, for papers by Lisa R. King Breakdown of academic impact, for papers by Ramesh Akkina Breakdown of academic impact, for papers by Michael S. Wyand Breakdown of academic impact, for papers by Helen C. Perry Breakdown of academic impact, for papers by Ke-Qin Xin
Rankless by CCL
2026